Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
18,444,750
-
Share change
-
-1,596,942
-
Total reported value
-
$41,310,590
-
Put/Call ratio
-
0%
-
Price per share
-
$2.24
-
Number of holders
-
48
-
Value change
-
-$3,104,500
-
Number of buys
-
19
-
Number of sells
-
27
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2021
As of 30 Sep 2021,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,444,750 shares.
The largest 10 holders included
BVF INC/IL, Omega Fund Management, LLC, VANGUARD GROUP INC, ALETHEA CAPITAL MANAGEMENT, LLC, 5AM Venture Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Stonepine Capital Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, ACADIAN ASSET MANAGEMENT LLC, and TWO SIGMA ADVISERS, LP.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.